Axios Pro Exclusive Content

Colossal Biosciences raises $150M to revive the dodo

illustration of a one hundred dollar bill with a dodo on it

Illustration: Tiffany Herring/Axios

Colossal Biosciences, the Austin-based "de-extinction" company that's bringing back the woolly mammoth and Tasmanian tiger, closed a $150 million Series B to fund a new effort to revive the dodo.

Why it matters: The climate movement, at its most fundamental level, is about protecting the Earth. Colossal Biosciences hopes to repair some of the damage already done.

Axios Pro

Unlock this article for free

Already a subscriber?

Axios may use your email in accordance with our Privacy Policy including for marketing purposes and promotional emails.

Go deeper